Literature DB >> 10406979

Benign multiple sclerosis? Clinical course, long term follow up, and assessment of prognostic factors.

S A Hawkins1, G V McDonnell.   

Abstract

OBJECTIVE: To establish the characteristics of patients following a benign course of multiple sclerosis and evaluate the importance of potential prognostic factors. Also, an assessment of the value of the Kurtzke EDSS as a prognostic indicator has been undertaken in patients previously determined to have benign multiple sclerosis, after 10 years of follow up.
METHODS: A prevalence study in the Coleraine, Ballymena, Ballymoney, and Moyle districts of Northern Ireland used the Kurtzke expanded disability scale score (EDSS) in 259 patients with multiple sclerosis. Of these, 181 had had multiple sclerosis for>/=10 years, 36 having benign disease (EDSS</=3.0) >/=10 years after onset. Clinical and demographic details of the various patient groups, including the minimal record of disability, were compared. The 1987 study in Northern Ireland identified 33 patients with benign multiple sclerosis. Twenty eight were available for follow up in 1996 along with 42 contemporary non-benign patients.
RESULTS: Patients with benign multiple sclerosis were predominantly women (ratio 4.1:1 v 2.1:1) and younger at onset (25.8 v 31.2 years). Commonest symptoms at onset were sensory and optic neuritis (33.3% each). Patients with late onset (older than 40 years) were less likely to have a benign course, more likely to have a progressive course from onset, significantly more likely to have motor disturbance at presentation, and had a lesser female predominance. Optic neuritis was significantly more common in those with a younger age at onset. In the follow up study, patients with benign multiple sclerosis continued to have a more favourable course than non-benign counterparts but progression of disability and to the secondary progressive phase remained significant.
CONCLUSIONS: The association of female sex, early onset, and presentation with optic neuritis and sensory symptoms with a favourable course is confirmed. However, although the EDSS does provide a useful indicator of prognosis, the label "benign multiple sclerosis" is often temporary as apparently benign disease often becomes disabling.

Entities:  

Mesh:

Year:  1999        PMID: 10406979      PMCID: PMC1736487          DOI: 10.1136/jnnp.67.2.148

Source DB:  PubMed          Journal:  J Neurol Neurosurg Psychiatry        ISSN: 0022-3050            Impact factor:   10.154


  27 in total

1.  An epidemiologic study of multiple sclerosis in Northern Ireland.

Authors:  G V McDonnell; S A Hawkins
Journal:  Neurology       Date:  1998-02       Impact factor: 9.910

2.  A clinical and laboratory study of benign multiple sclerosis.

Authors:  A J Thompson; M Hutchinson; J Brazil; C Feighery; E A Martin
Journal:  Q J Med       Date:  1986-01

3.  Disability due to multiple sclerosis: a community-based study on an Irish county.

Authors:  M Hutchinson
Journal:  Ir Med J       Date:  1986-02

4.  Clinical data and the identification of special forms of multiple sclerosis in 1271 cases studied with a standardized documentation system.

Authors:  S Poser; J Wikström; H J Bauer
Journal:  J Neurol Sci       Date:  1979-02       Impact factor: 3.181

5.  Prognostic factors in a multiple sclerosis incidence cohort with twenty-five years of follow-up.

Authors:  B Runmarker; O Andersen
Journal:  Brain       Date:  1993-02       Impact factor: 13.501

6.  A population-based study of multiple sclerosis in twins: update.

Authors:  A D Sadovnick; H Armstrong; G P Rice; D Bulman; L Hashimoto; D W Paty; S A Hashimoto; S Warren; W Hader; T J Murray
Journal:  Ann Neurol       Date:  1993-03       Impact factor: 10.422

7.  Unsuspected multiple sclerosis.

Authors:  J J Gilbert; M Sadler
Journal:  Arch Neurol       Date:  1983-09

8.  Defining the clinical course of multiple sclerosis: results of an international survey. National Multiple Sclerosis Society (USA) Advisory Committee on Clinical Trials of New Agents in Multiple Sclerosis.

Authors:  F D Lublin; S C Reingold
Journal:  Neurology       Date:  1996-04       Impact factor: 9.910

9.  Clinical parameters and intrathecal IgG synthesis as prognostic features in multiple sclerosis. Part I.

Authors:  E Verjans; P Theys; P Delmotte; H Carton
Journal:  J Neurol       Date:  1983       Impact factor: 4.849

10.  Presenting signs and symptoms in multiple sclerosis.

Authors:  E A Sanders; E L Bollen; E A van der Velde
Journal:  Acta Neurol Scand       Date:  1986-03       Impact factor: 3.209

View more
  51 in total

Review 1.  Management of secondary-progressive multiple sclerosis.

Authors:  Gavin Giovannoni
Journal:  CNS Drugs       Date:  2004       Impact factor: 5.749

2.  Overcoming the clinical-MR imaging paradox of multiple sclerosis: MR imaging data assessed with a random forest approach.

Authors:  K Kacar; M A Rocca; M Copetti; S Sala; S Mesaros; T Stosic Opincal; D Caputo; M Absinta; J Drulovic; V S Kostic; G Comi; M Filippi
Journal:  AJNR Am J Neuroradiol       Date:  2011-11-11       Impact factor: 3.825

Review 3.  Benign multiple sclerosis: does it exist?

Authors:  Jorge Correale; María C Ysrraelit; Marcela P Fiol
Journal:  Curr Neurol Neurosci Rep       Date:  2012-10       Impact factor: 5.081

Review 4.  The patient's journey: multiple sclerosis.

Authors:  Michaela Langgartner; Ingrid Langgartner; Marcus Drlicek
Journal:  BMJ       Date:  2005-04-16

Review 5.  Multiple sclerosis in the elderly patient.

Authors:  Amer Awad; Olaf Stüve
Journal:  Drugs Aging       Date:  2010-04-01       Impact factor: 3.923

Review 6.  Benign multiple sclerosis: some recent ideas.

Authors:  David M Dawson
Journal:  Curr Neurol Neurosci Rep       Date:  2008-01       Impact factor: 5.081

Review 7.  Clinical prognostic factors in multiple sclerosis: a natural history review.

Authors:  Alexandra Degenhardt; Sreeram V Ramagopalan; Antonio Scalfari; George C Ebers
Journal:  Nat Rev Neurol       Date:  2009-12       Impact factor: 42.937

8.  Neuropsychological deficits but not coping strategies are related to physical disability in multiple sclerosis.

Authors:  Claus G Haase; Marc Lienemann; Pedro M Faustmann
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2007-11-07       Impact factor: 5.270

9.  Clinical characteristics of patients with late-onset multiple sclerosis.

Authors:  Bernhard Kis; Bastian Rumberg; Peter Berlit
Journal:  J Neurol       Date:  2008-02-19       Impact factor: 4.849

10.  The diagnosis of multiple sclerosis and the clinical subtypes.

Authors:  Barrie J Hurwitz
Journal:  Ann Indian Acad Neurol       Date:  2009-10       Impact factor: 1.383

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.